Member States also highlight the need for good validation of testing technologies, and also pathogen inactivation technologies, in order to achieve an effective level of safety and quality.
Samuti rõhutavad liikmesriigid vajadust testimise ja ka patogeenide inaktiveerimise metoodikate asjakohase valideerimise järele, et saavutada ohutuse ja kvaliteedi tõhus tase.